Schwartz PE - Search Results

1

T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2.

Nicoletti R, Lopez S, Bellone S, Cocco E, Schwab CL, Black JD, Centritto F, Zhu L, Bonazzoli E, Buza N, Hui P, Mezzanzanica D, Canevari S, Schwartz PE, Rutherford TJ, Santin AD. Nicoletti R, et al. Among authors: schwartz pe. Clin Exp Metastasis. 2015 Jan;32(1):29-38. doi: 10.1007/s10585-014-9688-8. Epub 2014 Nov 15. Clin Exp Metastasis. 2015. PMID: 25398397 Free PMC article.

2

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner BC, Knisely JP, Kacinski BM, Haffty BG, Gumbs AA, Roberts KB, Frank AH, Peschel RE, Rutherford TJ, Edraki B, Kohorn EI, Chambers SK, Schwartz PE, Wilson LD. Turner BC, et al. Among authors: schwartz pe. Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84. doi: 10.1016/s0360-3016(97)00581-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9422561 Free article.

3

Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.

Schwartz PE, Rutherford TJ, Chambers JT, Kohorn EI, Thiel RP. Schwartz PE, et al. Gynecol Oncol. 1999 Jan;72(1):93-9. doi: 10.1006/gyno.1998.5236. Gynecol Oncol. 1999. PMID: 9889037 Free article.

4

Adenocarcinoma in situ of the cervix: management and outcome.

Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Azodi M, et al. Among authors: schwartz pe. Gynecol Oncol. 1999 Jun;73(3):348-53. doi: 10.1006/gyno.1999.5395. Gynecol Oncol. 1999. PMID: 10366458 Free article.

5

The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.

Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A. Peng XY, et al. Cancer Res. 2001 Jun 1;61(11):4405-13. Cancer Res. 2001. PMID: 11389068

6

Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure.

Yalcin OT, Rutherford TJ, Chambers SK, Chambers JT, Schwartz PE. Yalcin OT, et al. Among authors: schwartz pe. Eur J Obstet Gynecol Reprod Biol. 2003 Jan 10;106(1):64-8. doi: 10.1016/s0301-2115(02)00209-9. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12475584 Clinical Trial.

7

A pilot study of topotecan in the treatment of serous carcinoma of the uterus.

Chambers JT, Rutherford TJ, Schwartz PE, Carcangiu ML, Chambers SK, Baker L. Chambers JT, et al. Among authors: schwartz pe. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):216-22. doi: 10.1046/j.1525-1438.2003.13022.x. Int J Gynecol Cancer. 2003. PMID: 12657127 Clinical Trial.

8

Epithelial ovarian cancer cells secrete functional Fas ligand.

Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G. Abrahams VM, et al. Among authors: schwartz pe. Cancer Res. 2003 Sep 1;63(17):5573-81. Cancer Res. 2003. PMID: 14500397

9

Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.

Flick MB, O'Malley D, Rutherford T, Rodov S, Kamsteeg M, Hao XY, Schwartz P, Kacinski BM, Mor G. Flick MB, et al. J Soc Gynecol Investig. 2004 May;11(4):252-9. doi: 10.1016/j.jsgi.2003.11.003. J Soc Gynecol Investig. 2004. PMID: 15120700

10

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.

Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE. Zheng W, et al. Among authors: schwartz pe. Int J Surg Pathol. 2004 Jul;12(3):207-23. doi: 10.1177/106689690401200302. Int J Surg Pathol. 2004. PMID: 15306933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters